One such factor is the adipokine adiponectin, which is known to reduce hepatic lipid content [37] and to be present at lower levels in subjects with type 2 diabetes and predict progression to diabetes [38]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.